Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
Osteoporosis is a chronic skeletal disorder in which reduced bone strength confers sustained fracture risk, often necessitating long-term pharmacotherapy with a multi-phase approach rather than a single “one and done” drug choice. Contemporary guidelines ...